PTX-triggered immunogenic cell death (ICD) of tumor cells elicits a massive infiltration of tumor-reactive CD8+ T cells [2], which are considered central to anti-tumor effects and can act as a well-characterized biomarker for efficacy [3, 4]. The gene discussed is CD8A; the disease is neoplasm.